Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lafond

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2022
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trialY Tao, J Biau, X S Sun, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 27, 2018
[Siriade 2.0: An e-learning platform for radiation oncology contouring]J-E Bibault, F Denis, A Roué, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL studyH Bourgeois, F Grudé, P Solal-Céligny, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2022
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trialY Tao, J Biau, X S Sun, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 27, 2018
[Siriade 2.0: An e-learning platform for radiation oncology contouring]J-E Bibault, F Denis, A Roué, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL studyH Bourgeois, F Grudé, P Solal-Céligny, et al.
Pageof 6